Predicted length | n assess-ments | Sensitivity (95% CI) | Specificity (95% CI) | Likelihood ratio (95% CI) | PPV1 (95% CI) | PPV adjusted to prevalence 17.9%(95% CI) |
---|---|---|---|---|---|---|
Sick-listed >= 8 weeks | 152 | 0.69 (0.50–0.84) | 0.69 (0.60–0.77) | 2.2 (1.3–3.9) | 0.37 (0.25–0.51) | 0.33 (0.21–0.47) |
Sick-listed >= 12 weeks | 152 | 0.50 (0.32–0.68) | 0.83 (0.75–0.90) | 3.0 (1.5–6.1) | 0.44 (0.28–0.62) | 0.40 (0.24–0.58) |
Sick-listed >= 26 weeks | 152 | 0.28 (0.14–0.47) | 0.98 (0.94–1.00) | 16.9 (3.5–160) | 0.82 (0. 48–0.98) | 0.78 (0.44–0.95) |
Consultants >= 8 weeks | 1961 | 0.44 (0.39–0.49) | 0.72 (0.70–0.74) | 1.6 (1.3–1.9) | 0.25 (0.22–0.29) | |
Consultants >= 12 weeks | 1961 | 0.20 (0.16–0.24) | 0.92 (0.90–0.93) | 2.4 (1.8–3.2) | 0.35 (0.28–0.41) | |
Consultants >= 26 weeks | 1961 | 0.07 (0.04–0.10) | 0.99 (0.98–0.99) | 2.8 (1.5–5.4) | 0.54 (0.38–0.69) | |
Officers >= 8 weeks | 1968 | 0.55 (0.50–0.60) | 0.58 (0.56–0.61) | 1.3 (1.1–1.5) | 0.22 19.3–24.9 | |
Officers >= 12 weeks | 1968 | 0.26 (0.21–0.31) | 0.83 (0.81–0.85) | 1.6 (1.3–2.0) | 0.25 (0.20–0.29) | |
Officers >= 26 weeks | 1968 | 0.06 (0.04–0.09) | 0.98 (0.97–0.98) | 1.5 (0.9–2.6) | 0.34 (0.23–0.48) | |
SC2 | ||||||
Consultants >= 12 weeks | 637 | 0.89 (0.86–0.93) | 0.29 (0.25–0.34) | 1.3 (1.1–1.5) | 0.44 (0.40–0.48) | 0.22 (0.18–0.25) |
Consultants >= 26 weeks | 637 | 0.24 (0.19–0.29) | 0.96 (0.93–0.98) | 5.9 (3.4–11.0) | 0.79 (0.68–0.87) | 0.56 (0.41–0.70) |
Officers >= 12 weeks | 636 | 0.89 (0.85–0.93) | 0.21 (0.17–0.25) | 1.1 (0.9–1.3) | 0.41 (0.37–0.45) | 0.20 (0.16–0.23) |
Officers >= 26 weeks | 636 | 0.28 (0.22–0.34) | 0.90 (0.87–0.93) | 2.8 (1.9–4.3) | 0.64 (0.54–0.73) | 0.38 (0.28–0.49) |